XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Tables)
3 Months Ended
Dec. 31, 2025
Segment Information  
Schedule of significant expense categories

Three months ended December 31, 

2025

2024

Revenues, net

$

(1,207,833)

$

Cost of revenues

29,626

Gross profit

(1,237,459)

Operating expenses:

Research and development expenses

ONS-5010/LYTENAVA development

2,594,912

8,725,849

Compensation and related benefits

614,534

569,127

Stock-based compensation

97,818

110,029

Other research and development

327,088

255,145

3,634,352

9,660,150

Selling, general and administrative expenses

Professional fees

1,247,517

2,321,458

Compensation and related benefits

914,465

2,780,189

Stock-based compensation

783,332

3,562,391

Europe launch expenses

4,800,734

2,466,342

Facilities, fees and other related costs

866,093

816,322

8,612,141

11,946,702

Segment loss from operations

(13,483,952)

(21,606,852)

Other segment items (i)

(9,574,183)

38,984,466

Segment loss before income taxes

$

(23,058,135)

$

17,377,614